Back to Search Start Over

A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers

Authors :
Joëlle Micallef
J.L. Bourriez
Catherine Cassé-Perrot
Dominique Deplanque
Christopher Leroy
Pierre Payoux
Hervé Devanne
Sophie Hennion
Amélie Ponchel
Kathy Dujardin
Olivier Blin
Nicolas Chauveau
Laura Lanteaume
Régis Bordet
Behnam Molaee-Ardekani
Philippe Derambure
Céline Vervueren
François Guimont
Claire Thalamas
Déborah Méligne
Franck Rouby
Julie Deguil
Lucie Plomhause
Claudio Babiloni
Institut de Neurosciences des Systèmes (INS)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)
Source :
Clinical Neurophysiology, Clinical Neurophysiology, Elsevier, 2019, 130 (5), pp.863-875. ⟨10.1016/j.clinph.2015.11.018⟩
Publication Year :
2015

Abstract

Objective To identify possible electroencephalographic (EEG) markers of donepezil’s effect on cortical activity in young, healthy adult volunteers at the group level. Methods Thirty subjects were administered a daily dose of either 5 mg donepezil or placebo for 15 days in a double-blind, randomized, cross-over trial. The electroencephalogram during an auditory oddball paradigm was recorded from 58 scalp electrodes. Current source density (CSD) transformations were applied to EEG epochs. The event-related potential (ERP), inter-trial coherence (ITC: the phase consistency of the EEG spectrum) and event-related spectral perturbation (ERSP: the EEG power spectrum relative to the baseline) were calculated for the target (oddball) stimuli. Results The donepezil and placebo conditions differed in terms of the changes in delta/theta/alpha/beta ITC and ERSP in various regions of the scalp (especially the frontal electrodes) but not in terms of latency and amplitude of the P300-ERP component. Conclusion Our results suggest that ITC and ERSP analyses can provide EEG markers of donepezil’s effects in young, healthy, adult volunteers at a group level. Significance Novel EEG markers could be useful to assess the therapeutic potential of drug candidates in Alzheimer’s disease in healthy volunteers prior to the initiation of Phase II/III clinical studies in patients.

Details

ISSN :
18728952 and 13882457
Volume :
130
Issue :
5
Database :
OpenAIRE
Journal :
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Accession number :
edsair.doi.dedup.....9472ed5e95bc1ec889631e3e5a63e26b
Full Text :
https://doi.org/10.1016/j.clinph.2015.11.018⟩